Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wahl, Niklas Alexander, Lebrón-Acosta, Naiara, Pérez-Cuevas, Michelle, Hernandez-Mejias, Angel, Leshchiner, Dmitry, Valeriote, Frederick A, Caro-Diaz, Eduardo J E, Horibata, Sachi
Format: Artículo científico
Sprache:en
Veröffentlicht: Scientific reports 2025
Schlagworte:
Online-Zugang:https://pubmed.ncbi.nlm.nih.gov/41225047/
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1868266127733293057
author Wahl, Niklas Alexander
Lebrón-Acosta, Naiara
Pérez-Cuevas, Michelle
Hernandez-Mejias, Angel
Leshchiner, Dmitry
Valeriote, Frederick A
Caro-Diaz, Eduardo J E
Horibata, Sachi
author_facet Wahl, Niklas Alexander
Lebrón-Acosta, Naiara
Pérez-Cuevas, Michelle
Hernandez-Mejias, Angel
Leshchiner, Dmitry
Valeriote, Frederick A
Caro-Diaz, Eduardo J E
Horibata, Sachi
Wahl, Niklas Alexander
Lebrón-Acosta, Naiara
Pérez-Cuevas, Michelle
Hernandez-Mejias, Angel
Leshchiner, Dmitry
Valeriote, Frederick A
Caro-Diaz, Eduardo J E
Horibata, Sachi
collection PubMed - marine biology
contents Majusculamide-o, a simplified marine natural product analog, exhibits potent and specific cancer cell cytotoxicity. Wahl, Niklas Alexander Lebrón-Acosta, Naiara Pérez-Cuevas, Michelle Hernandez-Mejias, Angel Leshchiner, Dmitry Valeriote, Frederick A Caro-Diaz, Eduardo J E Horibata, Sachi Humans Biological Products Cell Line, Tumor Antineoplastic Agents Signal Transduction Neoplasms Female Cell Survival Metastatic solid tumors (e.g., ovary, pancreas, liver, lung, and brain) contribute to a high mortality rate in cancer patients with few therapeutically effective anticancer drugs available for their treatment, highlighting the need to develop agents that target solid tumors. Natural products (NPs) derived from cyanobacteria possess potent anticancer activity, yet most are hard to synthesize and modify to improve therapeutic efficacy. Here, we have efficiently synthesized a simplified analog of the marine NP majusculamide D, majusculamide o (maj-o, 1), that has remarkable potency and selective cytotoxicity towards various metastatic cancer cells. We found that maj-o (1) treatment presents potent cytotoxicity in various cancer cell lines of the ovary (OVCAR3), pancreas (PANC1), brain (U251N), and lung (H125) in a dose-dependent manner, with the least cytotoxic effect towards non-metastatic or primary tumors of the liver (HEPG2) and ovary (OVCAR8). 1 significantly alters gene expression signatures with more treatment time and affects pathways associated with PI3K-Akt signaling and the Hippo pathway. Our finding suggests that maj-o has great potential to serve as a lead compound for the development of novel antineoplastics for solid tumors.
format Artículo científico
id pubmed_41225047
institution PubMed
language en
publishDate 2025
publisher Scientific reports
record_format pubmed
spellingShingle Majusculamide-o, a simplified marine natural product analog, exhibits potent and specific cancer cell cytotoxicity.
Wahl, Niklas Alexander
Lebrón-Acosta, Naiara
Pérez-Cuevas, Michelle
Hernandez-Mejias, Angel
Leshchiner, Dmitry
Valeriote, Frederick A
Caro-Diaz, Eduardo J E
Horibata, Sachi
Humans
Biological Products
Cell Line, Tumor
Antineoplastic Agents
Signal Transduction
Neoplasms
Female
Cell Survival
Majusculamide-o, a simplified marine natural product analog, exhibits potent and specific cancer cell cytotoxicity. Wahl, Niklas Alexander Lebrón-Acosta, Naiara Pérez-Cuevas, Michelle Hernandez-Mejias, Angel Leshchiner, Dmitry Valeriote, Frederick A Caro-Diaz, Eduardo J E Horibata, Sachi Humans Biological Products Cell Line, Tumor Antineoplastic Agents Signal Transduction Neoplasms Female Cell Survival Metastatic solid tumors (e.g., ovary, pancreas, liver, lung, and brain) contribute to a high mortality rate in cancer patients with few therapeutically effective anticancer drugs available for their treatment, highlighting the need to develop agents that target solid tumors. Natural products (NPs) derived from cyanobacteria possess potent anticancer activity, yet most are hard to synthesize and modify to improve therapeutic efficacy. Here, we have efficiently synthesized a simplified analog of the marine NP majusculamide D, majusculamide o (maj-o, 1), that has remarkable potency and selective cytotoxicity towards various metastatic cancer cells. We found that maj-o (1) treatment presents potent cytotoxicity in various cancer cell lines of the ovary (OVCAR3), pancreas (PANC1), brain (U251N), and lung (H125) in a dose-dependent manner, with the least cytotoxic effect towards non-metastatic or primary tumors of the liver (HEPG2) and ovary (OVCAR8). 1 significantly alters gene expression signatures with more treatment time and affects pathways associated with PI3K-Akt signaling and the Hippo pathway. Our finding suggests that maj-o has great potential to serve as a lead compound for the development of novel antineoplastics for solid tumors.
title Majusculamide-o, a simplified marine natural product analog, exhibits potent and specific cancer cell cytotoxicity.
topic Humans
Biological Products
Cell Line, Tumor
Antineoplastic Agents
Signal Transduction
Neoplasms
Female
Cell Survival
url https://pubmed.ncbi.nlm.nih.gov/41225047/